Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Dry Eye Syndrome (des) Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

4 recruiting trials for Dry Eye Syndrome (des). Eligibility criteria explained in plain English.

TrialFinderData lists 4 Dry Eye Syndrome (des) clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Across the trials that carry a phase, Phase 2 is the largest group at 50% (1 studies); the largest phase groups are Phase 2: 1, Phase 4: 1.

Research is led by Taipei Veterans General Hospital, Taiwan (2), Vance Thompson Vision (1), Pleryon Therapeutics (Hangzhou) Limited (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Laser acupuncture (LA) (other, 1 trial), followed by Numerical Rating Scale (NRS), Schirmer's test.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
4
Total Trials
4
Recruiting Now
0
Phase 3 Trials
3
Sponsors

Track Dry Eye Syndrome (des) trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGPhase 2NCT06780293

Laser Acupuncture on Dry Eye and Sjögren's Syndrome-related Dry Eye Symptoms (LADESJS)

This randomized, double-blind, placebo-controlled clinical trial aims to evaluate the efficacy of adding laser acupuncture at Fengchi (GB20), Zanzhu (BL2), Hegu (LI4), and Quchi...

Sponsor: Taipei Veterans General Hospital, TaiwanEnrolling: 1401 location
RECRUITINGPhase 4NCT07650708

A Multicenter, Open-Label Study to Evaluate Perioperative Treatment of Dry Eye With Miebo® in Subjects Undergoing LASIK

Compare eye dryness following laser-assisted in situ keratomileusis (LASIK) surgery to eye dryness prior to receiving perioperative Miebo in patients with dry eye disease (DED)

Sponsor: Vance Thompson VisionEnrolling: 1004 locations
RECRUITINGNCT07593404

Evaluation of a Novel Ocular Lubricating Eye Drop

The objective of this 2-part study is to assess the safety and tolerability of the new ocular lubricating drop ABR2 during short-term use in subjects for the temporary relief of...

Sponsor: Pleryon Therapeutics (Hangzhou) LimitedEnrolling: 401 location
RECRUITINGNCT06771427

Exosomes Proteomic for Sjogren's Syndrome and Dry Eye Syndrome

By analyzing the differential proteins in exosomes, this study aims to understand the pathological mechanisms of SJS and DES, identify potential diagnostic and therapeutic...

Sponsor: Taipei Veterans General Hospital, TaiwanEnrolling: 2201 location

Frequently Asked Questions

There are currently 4 clinical trials for Dry Eye Syndrome (des), with 4 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Dry Eye Syndrome (des), review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Dry Eye Syndrome (des), representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.